Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.6000
+0.3497 (139.71%)
Sep 16, 2026, 4:00 PM EST
Biomind Labs Market Cap
Biomind Labs has a market cap or net worth of $19.42 million as of September 18, 2026. Its market cap has increased by 1,484.18% in one year.
Market Cap
19.42M
Enterprise Value
20.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.60
ChartMarket Cap Chart
Since July 27, 2021, Biomind Labs's market cap has increased from 18.69M to 19.42M, an increase of 3.88%. That is a compound annual growth rate of 0.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 19.42M | 119.56% |
| Dec 30, 2025 | 8.84M | -67.68% |
| Dec 19, 2022 | 27.36M | 46.40% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProText Mobility | 30.77M |
| Cell Source | 29.90M |
| Vicapsys Life Sciences | 27.52M |
| Zenith Capital | 24.17M |
| Provectus Biopharmaceuticals | 23.12M |
| EOM Pharmaceuticals Holdings | 20.51M |
| Finch Therapeutics Group | 16.62M |
| Inhibitor Therapeutics | 15.45M |